KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa04110
|
Cell cycle |
CCND1,CDK6,CCNE2,CDC25A,HDAC1,CDK4, |
9.65E-7 |
hsa05200
|
Pathways in cancer |
CCND1,CDK6,CCNE2,BCL2,HDAC1,CDK4,MET, |
4.90E-6 |
hsa05222
|
Small cell lung cancer |
CCND1,CDK6,CCNE2,BCL2,CDK4, |
8.20E-6 |
hsa04115
|
p53 signaling pathway |
CCND1,CDK6,CCNE2,CDK4, |
1.81E-4 |
hsa05218
|
Melanoma |
CCND1,CDK6,CDK4,MET, |
2.06E-4 |
|
hsa05220
|
Chronic myeloid leukemia |
CCND1,CDK6,HDAC1,CDK4, |
2.42E-4 |
hsa05223
|
Non-small cell lung cancer |
CCND1,CDK6,CDK4, |
3.79E-2 |
hsa05214
|
Glioma |
CCND1,CDK6,CDK4, |
5.14E-2 |
hsa05212
|
Pancreatic cancer |
CCND1,CDK6,CDK4, |
6.67E-2 |
hsa05210
|
Colorectal cancer |
CCND1,BCL2,MET, |
9.00E-2 |
hsa05215
|
Prostate cancer |
CCND1,CCNE2,BCL2, |
1.00E-1 |
hsa04510
|
Focal adhesion |
CCND1,BCL2,MET, |
4.66E-1 |
hsa05219
|
Bladder cancer |
CCND1,CDK4, |
7.19E-1 |
hsa04330
|
Notch signaling pathway |
NOTCH1,HDAC1, |
8.02E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0051726
|
regulation of cell cycle |
CCND1,CDK6,CCNE2,HNF4A,BCL2,CDC25A,HDAC1,CDK4,GMNN, |
1.36E-10 |
GO:0042127
|
regulation of cell proliferation |
CCND1,CDK6,HNF4A,BCL2,WISP2,NOTCH1,HDAC1,CDK4,SIRT1, |
1.25E-7 |
GO:0045786
|
negative regulation of cell cycle |
CDK6,HNF4A,BCL2,HDAC1,GMNN, |
8.18E-7 |
GO:0051329
|
interphase of mitotic cell cycle |
CCND1,CDK6,BCL2,CDC25A,CDK4, |
2.14E-6 |
GO:0051325
|
interphase |
CCND1,CDK6,BCL2,CDC25A,CDK4, |
2.41E-6 |
|
GO:0051301
|
cell division |
CCND1,CDK6,CCNE2,CDC25A,NOTCH1,CDK4, |
5.31E-6 |
GO:0000082
|
G1/S transition of mitotic cell cycle |
CCND1,BCL2,CDC25A,CDK4, |
1.86E-5 |
GO:0008284
|
positive regulation of cell proliferation |
CCND1,CDK6,BCL2,NOTCH1,HDAC1,CDK4, |
2.75E-5 |
GO:0045596
|
negative regulation of cell differentiation |
CCND1,CDK6,NOTCH1,HDAC1,SIRT1, |
4.03E-5 |
GO:0007049
|
cell cycle |
CCND1,CDK6,CCNE2,BCL2,CDC25A,CDK4,GMNN, |
4.23E-5 |
GO:0042325
|
regulation of phosphorylation |
CCND1,CCNE2,HNF4A,BCL2,CDC25A,MET, |
4.85E-5 |
GO:0051174
|
regulation of phosphorus metabolic process |
CCND1,CCNE2,HNF4A,BCL2,CDC25A,MET, |
5.88E-5 |
GO:0019220
|
regulation of phosphate metabolic process |
CCND1,CCNE2,HNF4A,BCL2,CDC25A,MET, |
5.88E-5 |
GO:0010551
|
regulation of specific transcription from RNA polymerase II promoter |
HNF4A,NOTCH1,HDAC1,SIRT1, |
8.83E-5 |
GO:0016575
|
histone deacetylation |
HDAC1,SIRT1,HDAC8, |
1.14E-4 |
GO:0006476
|
protein amino acid deacetylation |
HDAC1,SIRT1,HDAC8, |
1.94E-4 |
GO:0048742
|
regulation of skeletal muscle fiber development |
BCL2,NOTCH1,HDAC1, |
2.52E-4 |
GO:0032583
|
regulation of gene-specific transcription |
HNF4A,NOTCH1,HDAC1,SIRT1, |
2.52E-4 |
GO:0000278
|
mitotic cell cycle |
CCND1,CDK6,BCL2,CDC25A,CDK4, |
3.23E-4 |
GO:0048641
|
regulation of skeletal muscle tissue development |
BCL2,NOTCH1,HDAC1, |
3.41E-4 |
GO:0051153
|
regulation of striated muscle cell differentiation |
BCL2,NOTCH1,HDAC1, |
4.16E-4 |
GO:0022403
|
cell cycle phase |
CCND1,CDK6,BCL2,CDC25A,CDK4, |
4.96E-4 |
GO:0051147
|
regulation of muscle cell differentiation |
BCL2,NOTCH1,HDAC1, |
6.19E-4 |
GO:0010604
|
positive regulation of macromolecule metabolic process |
CCND1,HNF4A,BCL2,NOTCH1,HDAC1,CDK4, |
8.45E-4 |
GO:0016202
|
regulation of striated muscle tissue development |
BCL2,NOTCH1,HDAC1, |
1.01E-2 |
GO:0048634
|
regulation of muscle development |
BCL2,NOTCH1,HDAC1, |
1.05E-2 |
GO:0000079
|
regulation of cyclin-dependent protein kinase activity |
CCND1,CCNE2,CDC25A, |
1.18E-2 |
GO:0010552
|
positive regulation of specific transcription from RNA polymerase II promoter |
HNF4A,NOTCH1,HDAC1, |
1.32E-2 |
GO:0006796
|
phosphate metabolic process |
CCND1,CDK6,BCL2,CDC25A,CDK4,MET, |
1.50E-2 |
GO:0006793
|
phosphorus metabolic process |
CCND1,CDK6,BCL2,CDC25A,CDK4,MET, |
1.50E-2 |
GO:0022402
|
cell cycle process |
CCND1,CDK6,BCL2,CDC25A,CDK4, |
1.59E-2 |
GO:0031099
|
regeneration |
CCND1,BCL2,NOTCH1, |
1.92E-2 |
GO:0006468
|
protein amino acid phosphorylation |
CCND1,CDK6,BCL2,CDK4,MET, |
2.92E-2 |
GO:0043193
|
positive regulation of gene-specific transcription |
HNF4A,NOTCH1,HDAC1, |
3.04E-2 |
GO:0045859
|
regulation of protein kinase activity |
CCND1,CCNE2,CDC25A,MET, |
3.88E-2 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
HNF4A,NOTCH1,HDAC1,SIRT1,HDAC8, |
4.00E-2 |
GO:0010605
|
negative regulation of macromolecule metabolic process |
HNF4A,HDAC1,GMNN,SIRT1,HDAC8, |
4.14E-2 |
GO:0043549
|
regulation of kinase activity |
CCND1,CCNE2,CDC25A,MET, |
4.28E-2 |
GO:0008285
|
negative regulation of cell proliferation |
CDK6,HNF4A,BCL2,WISP2, |
4.41E-2 |
GO:0051338
|
regulation of transferase activity |
CCND1,CCNE2,CDC25A,MET, |
4.80E-2 |
GO:0008406
|
gonad development |
CCND1,BCL2,SIRT1, |
4.99E-2 |
GO:0016310
|
phosphorylation |
CCND1,CDK6,BCL2,CDK4,MET, |
5.64E-2 |
GO:0016570
|
histone modification |
HDAC1,SIRT1,HDAC8, |
5.89E-2 |
GO:0048608
|
reproductive structure development |
CCND1,BCL2,SIRT1, |
6.27E-2 |
GO:0016569
|
covalent chromatin modification |
HDAC1,SIRT1,HDAC8, |
6.27E-2 |
GO:0045137
|
development of primary sexual characteristics |
CCND1,BCL2,SIRT1, |
6.37E-2 |
GO:0048511
|
rhythmic process |
BCL2,CDK4,SIRT1, |
6.47E-2 |
GO:0032880
|
regulation of protein localization |
HNF4A,BCL2,SIRT1, |
7.48E-2 |
GO:0033158
|
regulation of protein import into nucleus, translocation |
HNF4A,SIRT1, |
8.61E-2 |
GO:0007548
|
sex differentiation |
CCND1,BCL2,SIRT1, |
8.90E-2 |
GO:0007346
|
regulation of mitotic cell cycle |
CCND1,HNF4A,BCL2, |
9.01E-2 |
GO:0051098
|
regulation of binding |
HNF4A,BCL2,SIRT1, |
9.13E-2 |
GO:0032268
|
regulation of cellular protein metabolic process |
CCND1,HNF4A,BCL2,CDK4, |
9.40E-2 |
|
|
|
|
|
|